(LLYVA) Liberty Media Series - Ratings and Ratios
Live Promotions, Ticketing, Advertising, Sponsorships, Investments
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 29.4% |
| Value at Risk 5%th | 43.0% |
| Relative Tail Risk | -10.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 3.74 |
| CAGR/Max DD | 1.72 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.468 |
| Beta | 0.956 |
| Beta Downside | 0.973 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.36% |
| Mean DD | 7.33% |
| Median DD | 6.27% |
Description: LLYVA Liberty Media Series November 03, 2025
Liberty Live Group (NASDAQ: LLYVA) is a U.S.–based live-entertainment firm that promotes concerts, sells tickets both directly and for third-party venues, and monetizes its platform through advertising and sponsorship relationships. The company also maintains a diversified portfolio of public and private equity investments.
Key industry signals that shape Liberty Live’s outlook include: (1) a rebound in discretionary consumer spending, with the National Association of Theatre Owners reporting a 9% YoY increase in ticket revenue for live music in 2023; (2) average ticket prices rising to roughly $85, driven by premium seating and dynamic pricing models; and (3) sponsorship spend in the entertainment sector climbing 6% annually as brands seek experiential activation, which directly benefits Liberty Live’s advertising arm. Internally, Liberty Live disclosed 12 million tickets sold in 2023, an 8% increase from the prior year, and a 15% contribution margin from its ticketing operations.
For a deeper quantitative breakdown of Liberty Live’s valuation metrics, you might find the ValueRay platform’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-269.0m TTM) > 0 and > 6% of Revenue (6% = 1.56b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 6.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| error: NWC/Revenue cannot be calculated (needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.05 (>3.0%) and CFO 828.4m > Net Income -269.0m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (91.8m) change vs 12m ago 0.12% (target <= -2.0% for YES) |
| error: Gross Margin (current vs previous) cannot be calculated (needs Total Revenue and Cost Of Revenue) |
| Asset Turnover 283.5% (prev 0.0%; Δ 283.5pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.19 (EBITDA TTM -52.0m / Interest Expense TTM 108.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.40
| (A) -0.11 = (Total Current Assets 1.65b - Total Current Liabilities 3.53b) / Total Assets 17.11b |
| (B) 0.43 = Retained Earnings (Balance) 7.44b / Total Assets 17.11b |
| (C) -0.01 = EBIT TTM -129.0m / Avg Total Assets 9.18b |
| (D) 0.76 = Book Value of Equity 7.38b / Total Liabilities 9.73b |
| Total Rating: 1.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.70
| 1. Piotroski 3.0pt |
| 2. FCF Yield 10.46% |
| 3. FCF Margin 3.22% |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda -6.29 |
| 6. ROIC - WACC (= -24.08)% |
| 7. RoE -17.55% |
| 8. Rev. Trend 80.10% |
| 9. EPS Trend -61.64% |
What is the price of LLYVA shares?
Over the past week, the price has changed by +0.18%, over one month by +8.60%, over three months by -12.33% and over the past year by +21.01%.
Is LLYVA a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LLYVA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116 | 41% |
| Analysts Target Price | 116 | 41% |
| ValueRay Target Price | 91.5 | 11.2% |
LLYVA Fundamental Data Overview December 22, 2025
P/E Forward = 41.4938
P/B = 0.3351
Beta = 1.357
Revenue TTM = 26.03b USD
EBIT TTM = -129.0m USD
EBITDA TTM = -52.0m USD
Long Term Debt = 1.56b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.92b USD (from shortTermDebt, last quarter)
Debt = 1.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 327.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.01b USD (7.68b + Debt 1.92b - CCE 1.59b)
Interest Coverage Ratio = -1.19 (Ebit TTM -129.0m / Interest Expense TTM 108.0m)
FCF Yield = 10.46% (FCF TTM 837.8m / Enterprise Value 8.01b)
FCF Margin = 3.22% (FCF TTM 837.8m / Revenue TTM 26.03b)
Net Margin = -1.03% (Net Income TTM -269.0m / Revenue TTM 26.03b)
Gross Margin = 93.48% ((Revenue TTM 26.03b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Gross Margin QoQ = 41.84% (prev 41.91%)
Tobins Q-Ratio = 0.47 (Enterprise Value 8.01b / Total Assets 17.11b)
Interest Expense / Debt = 4.49% (Interest Expense 86.0m / Debt 1.92b)
Taxrate = -43.48% (negative due to tax credits) (-10.0m / 23.0m)
NOPAT = -185.1m (EBIT -129.0m * (1 - -43.48%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.47 (Total Current Assets 1.65b / Total Current Liabilities 3.53b)
Debt / Equity = 0.26 (Debt 1.92b / totalStockholderEquity, last quarter 7.38b)
Debt / EBITDA = -6.29 (negative EBITDA) (Net Debt 327.0m / EBITDA -52.0m)
Debt / FCF = 0.39 (Net Debt 327.0m / FCF TTM 837.8m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.57% (Net Income -269.0m / Total Assets 17.11b)
RoE = -17.55% (Net Income TTM -269.0m / Total Stockholder Equity 1.53b)
RoCE = -4.18% (EBIT -129.0m / Capital Employed (Equity 1.53b + L.T.Debt 1.56b))
RoIC = -15.16% (negative operating profit) (NOPAT -185.1m / Invested Capital 1.22b)
WACC = 8.92% (E(7.68b)/V(9.60b) * Re(9.54%) + D(1.92b)/V(9.60b) * Rd(4.49%) * (1-Tc(-0.43)))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.05%
[DCF Debug] Terminal Value 64.00% ; FCFE base≈837.8m ; Y1≈550.0m ; Y5≈251.5m
Fair Price DCF = 153.5 (DCF Value 3.92b / Shares Outstanding 25.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -61.64 | EPS CAGR: -23.64% | SUE: -1.69 | # QB: 0
Revenue Correlation: 80.10 | Revenue CAGR: 21.18% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.84 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+182.9% | Growth Revenue=+517.9%
Additional Sources for LLYVA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle